These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Use of a new drug with sympatholytic and analgesic action in therapy of chronic juvenile and arteriosclerotic peripheral obliterating arteriopathy]. GUAGLIANO G; STOPPANI L Minerva Chir; 1958 Nov; 13(21):1282-6. PubMed ID: 13622298 [No Abstract] [Full Text] [Related]
4. [Mechanism of action of various anticoagulant drugs used in the therapy of obstetrical & gynecological phlebothrombosis & thrombophlebitis]. MALAGOLI F Ann Ostet Ginecol; 1956 Aug; 78(8):861-74. PubMed ID: 13459081 [No Abstract] [Full Text] [Related]
5. [Anticoagulant therapy of a case of priapism]. MARAGNANI U Minerva Urol; 1958; 10(3):67-9. PubMed ID: 13565845 [No Abstract] [Full Text] [Related]
6. [Prolonged treatment of peripheral arterial diseases with Tromexan]. LANFRANCHI W; DEGNI M Arq Bras Med; 1960; 50():499-502. PubMed ID: 14462031 [No Abstract] [Full Text] [Related]
7. [Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease]. Guliamov KhG Ter Arkh; 1974; 46(9):75-80. PubMed ID: 4439311 [No Abstract] [Full Text] [Related]
8. [Control of anticoagulant therapy with Pelentan. Results of the work of 20 laboratories]. Vorlová Z; Sikorová J Cas Lek Cesk; 1982 Dec; 121(49):1515-7. PubMed ID: 7151121 [No Abstract] [Full Text] [Related]
9. [Various current problems associated with anticoagulant therapy using Pelentan]. Donner L; Klener P Vnitr Lek; 1977 Sep; 23(9):880-6. PubMed ID: 919363 [No Abstract] [Full Text] [Related]
10. [The effect of anticoagulant therapy in patients with congestive cardiomyopathy]. Polić S; Rumboldt Z; Bagatin J; Metlicić S; Rakić D; Vucenik I Lijec Vjesn; 1988; 110(1-2):9-12. PubMed ID: 3283487 [No Abstract] [Full Text] [Related]
11. [Anticoagulant treatment following thrombolytic therapy]. Ohler WG Med Klin; 1966 Jan; 61(4):140-2. PubMed ID: 5983159 [No Abstract] [Full Text] [Related]
12. Long-term treatment of some arteriopathies with tromexan. CASTRO CM; STRITZLER G Angiology; 1955 Oct; 6(5):442-61. PubMed ID: 13275752 [No Abstract] [Full Text] [Related]
13. Evaluation of anticoagulant therapy in focal ischemic cerebrovascular disease: further observations. Siekert RG Res Publ Assoc Res Nerv Ment Dis; 1966; 41():359-66. PubMed ID: 4163329 [No Abstract] [Full Text] [Related]
14. The value of anticoagulant therapy in the treatment of acute myocardial infarction. McCLUSKIE JA; SEATON DA Scott Med J; 1959 Jun; 4(6):305-9. PubMed ID: 13668583 [No Abstract] [Full Text] [Related]
15. [Results of anticoagulant treatment of myocardial Infarction with thromexane]. KOVACEVIC M; NIKOLIC B; SLAVKOVIC J; SUTILOVIC B Srp Arh Celok Lek; 1956 Sep; 84(9):985-97. PubMed ID: 13391272 [No Abstract] [Full Text] [Related]
16. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions]. PANCONESI E Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261 [No Abstract] [Full Text] [Related]
17. [Our experience with postoperative preventive anticoagulant treatment. Apropos of 348 pneumonectomies]. Gaillard J; Eschapasse H; Bierme R; Henry E; Boneu B; Marschal J Ann Chir Thorac Cardiovasc; 1971 Jul; 10(3):339-47. PubMed ID: 5569097 [No Abstract] [Full Text] [Related]
18. [Lytic cocktail in therapy of chronic obliterating arteriopathy]. D'ANCONA G Minerva Chir; 1955 Feb; 10(3):120-6. PubMed ID: 14369777 [No Abstract] [Full Text] [Related]
19. An effect of drugs derived from 4-hydroxycoumarins not depending on hypoprothrombinaemia. DERECHIN M Arch Int Pharmacodyn Ther; 1957 Aug; 111(3):362-5. PubMed ID: 13459521 [No Abstract] [Full Text] [Related]
20. [New therapy of peripheral arteriopathy]. FISCHMAN S Sem Med; 1958 May; 112(21):862-4. PubMed ID: 13580363 [No Abstract] [Full Text] [Related] [Next] [New Search]